Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19578774

Download in:

View as

General Info

PMID
19578774